Next Generation Sequencing (NGS) Market, valued at USD 8.3 Bn in 2023, is projected to reach USD 39.1 Bn by 2032, growing at a CAGR of 19.1%. Key drivers include advancements in genomic research, personalized medicine, and reduced sequencing costs.
It is anticipated that by 2030, the market will surge to an astounding USD 21,485.69 million, reflecting an impressive CAGR of 20.54% from 2023 through 2030.
